Cadila to Commence Phase I Clinical Trials On ZYH2
Cadila Healthcare Ltd today said it has received approval from Drug Controller General of India (DCGI) to conduct Phase I clinical trials on its New Molecular Entity// (NME) - ZYH2, used for treating diabetes. In pre-clinical studies on 'ZY H2' displayed that it has the potential to improve i...Moneycontrol >> News Search result for DCGI
Jul-28-06 Zydus Cadila to commence Phase I clinical trials on ZYH2 ... Mar-27-06 Zydus Cadila files IND application for NME - ZYH2 ...China Business Directory > Search result
business directory: Chinese companies, importers, exporters, manufacturers ... ZYH2-700 salted egg yolk dryer; ZYH1-500 salted egg yolk drying oven; ZYX-Z1 egg ...Zydus Cadila files IND application for NME - ZYH2 - Express Pharma
With this filing, Zydus Cadila has filed three INDs - ZYH1, ZYH and ZYH2. ... The pre-clinical studies on ZYH2 indicate that this NME may be more effective ...domain-b.com : Zydus Cadila files novel drug candidate for obesity ...
Zydus Cadila files novel drug candidate for obesity disorders ... for phase II trials and ZYH2 undergoing phase I trial, we are building up an ...Zydus Cadila in RandD pact with Eli Lilly
Ahmedabad-based Zydus Cadila (__CADILAHC.NS__) has signed a new drug discovery ... ZYH2, the novel agent for treating diabetes is undergoing phase I trials. ...